The US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the test developed by Abbot Labs
Guwahati: Abbott Laboratories, an American medical device and health care company has unveiled a portable test kit which can detect positive cases of coronavirus in as little as five minutes and negative results in 13 minutes, said a press release by the company.
It said that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the test.
The test kit is small, lightweight and portable, and uses molecular technology, which is valued by clinicians and the scientific community for its high degree of accuracy. It will help in bringing rapid testing to the forefront.
"The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus," said Robert B Ford, president and chief operating officer, Abbott.
"With rapid testing on ID NOW, healthcare providers can perform molecular point-of-care testing outside the traditional four walls of a hospital in outbreak hotspots," added the press release.
The test will be available next week to healthcare providers in urgent care settings in US.
The test has not been cleared or approved by the FDA, and has only been authorized for emergency use by approved labs and healthcare providers, the company said.